Medicalgorithmics S.A. (WSE:MDG)
Poland · Delayed Price · Currency is PLN 26.95
-0.05 (-0.19%)
Jun 19, 2026, 5:00 PM CET
Medicalgorithmics Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 34.45 | 30.99 | 24 | 43.1 | 62.72 | 48.35 | |
Revenue Growth (YoY) | 45.02% | 29.09% | -44.31% | -31.28% | 29.72% | -56.73% |
Cost of Revenue | 16.07 | 18.07 | 22.44 | 26.12 | 29.52 | 22.84 |
Gross Profit | 18.38 | 12.92 | 1.57 | 16.98 | 33.2 | 25.51 |
Selling, General & Admin | 20.3 | 18.8 | 15.67 | 13.39 | 12.22 | 8.7 |
Other Operating Expenses | -0.95 | -0.77 | -0.64 | 1.51 | 1.01 | 0.53 |
Operating Expenses | 24.45 | 22.67 | 18.67 | 17.26 | 17.24 | 13.41 |
Operating Income | -6.07 | -9.76 | -17.1 | -0.28 | 15.96 | 12.1 |
Interest Expense | -2.56 | -2.04 | -0.16 | -0.11 | -0.27 | -0.61 |
Interest & Investment Income | - | - | 0.23 | 0.75 | - | 0.24 |
Currency Exchange Gain (Loss) | -0.62 | -0.06 | 0.48 | -1.35 | 8.08 | 2.9 |
Other Non Operating Income (Expenses) | 0.22 | 0.16 | 0.22 | 0.04 | 0.24 | 0.11 |
EBT Excluding Unusual Items | -9.02 | -11.7 | -16.34 | -0.95 | 24.01 | 14.73 |
Gain (Loss) on Sale of Investments | - | - | 2.62 | - | - | - |
Asset Writedown | - | - | -2.06 | 0.71 | - | -21.74 |
Other Unusual Items | - | - | - | - | 1.26 | - |
Pretax Income | -9.02 | -11.7 | -15.78 | -0.24 | 25.26 | -7.01 |
Income Tax Expense | 0.6 | -0.02 | 0.3 | 0.34 | -0.22 | -0.44 |
Earnings From Continuing Operations | -9.62 | -11.68 | -16.08 | -0.58 | 25.48 | -6.57 |
Earnings From Discontinued Operations | - | - | - | - | -37.34 | -174.07 |
Net Income to Company | -9.62 | -11.68 | -16.08 | -0.58 | -11.86 | -180.64 |
Minority Interest in Earnings | -0.01 | -0.01 | -0 | - | - | - |
Net Income | -9.63 | -11.68 | -16.08 | -0.58 | -11.86 | -180.64 |
Net Income to Common | -9.63 | -11.68 | -16.08 | -0.58 | -11.86 | -180.64 |
Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 6 | 5 |
Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 6 | 5 |
Shares Change (YoY) | - | - | - | 74.58% | 25.38% | 9.88% |
EPS (Basic) | -0.97 | -1.17 | -1.62 | -0.06 | -2.08 | -39.73 |
EPS (Diluted) | -0.97 | -1.17 | -1.62 | -0.06 | -2.08 | -39.73 |
Free Cash Flow | -0.5 | -2.14 | -13.22 | -0.31 | 6.33 | -16.39 |
Free Cash Flow Per Share | -0.05 | -0.21 | -1.33 | -0.03 | 1.11 | -3.60 |
Gross Margin | 53.36% | 41.69% | 6.53% | 39.40% | 52.94% | 52.76% |
Operating Margin | -17.61% | -31.49% | -71.24% | -0.65% | 25.44% | 25.03% |
Profit Margin | -27.96% | -37.71% | -67.00% | -1.34% | -18.91% | -373.61% |
Free Cash Flow Margin | -1.46% | -6.89% | -55.07% | -0.71% | 10.09% | -33.90% |
EBITDA | -5.48 | -9.23 | -16.55 | 0.14 | 16.6 | 22.05 |
EBITDA Margin | -15.90% | -29.78% | -68.96% | 0.33% | 26.47% | 45.61% |
D&A For EBITDA | 0.59 | 0.53 | 0.55 | 0.42 | 0.64 | 9.95 |
EBIT | -6.07 | -9.76 | -17.1 | -0.28 | 15.96 | 12.1 |
EBIT Margin | -17.61% | -31.49% | -71.24% | -0.65% | 25.44% | 25.03% |